Dr. Casey O'Connell, MD
Claim this profileUniversity of Southern California
Studies Myelodysplastic syndrome
Studies Myelodysplastic Syndrome
9 reported clinical trials
13 drugs studied
Area of expertise
1Myelodysplastic Syndrome
Stage IV
RARA positive
2Myelodysplastic Syndrome
Stage IV
RARA positive
Affiliated Hospitals
Clinical Trials Casey O'Connell, MD is currently running
Tamibarotene + Azacitidine
for Myelodysplastic Syndrome
This study compares the efficacy of Tamibarotene in combination with azacitidine to azacitidine in combination with placebo in participants who are Retinoic Acid Receptor Alpha (RARA) positive, and newly diagnosed with higher-risk myelodysplastic syndrome (HR-MDS), and who have not received treatment for this diagnosis. The primary goal of the study is to compare the complete remission rate between the two treatment arms.
Recruiting1 award Phase 34 criteria
Curcumin Supplement
for Myelodysplastic Syndrome and Myeloproliferative Disorders
This phase II trial evaluates how a curcumin supplement (C3 complex/Bioperine) changes the inflammatory response and symptomatology in patients with clonal cytopenia of undetermined significance (CCUS), low risk myelodysplastic syndrome (LR-MDS), and myeloproliferative neoplasms (MPN). Chronic inflammation drives disease development and contributes to symptoms experienced by patients with CCUS, LR-MDS, and MPN. Curcumin has been shown to have anti-inflammatory and anti-cancer properties and has been studied in various chronic illnesses and hematologic diseases.
Recruiting0 awards Phase 210 criteria
More about Casey O'Connell, MD
Clinical Trial Related7 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Casey O'Connell, MD has experience with
- Curcumin/ Demethoxycurcumin/Bisdemethoxycurcumin-containing Supplement
- Atezolizumab
- Guadecitabine
- Danazol
- Pelabresib (CPI-0610)
- Azacitidine
Breakdown of trials Casey O'Connell, MD has run
Myelodysplastic syndrome
Myelodysplastic Syndrome
Low blood cell count
Postprandial Fullness Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Casey O'Connell, MD specialize in?
Casey O'Connell, MD focuses on Myelodysplastic syndrome and Myelodysplastic Syndrome. In particular, much of their work with Myelodysplastic syndrome has involved Stage IV patients, or patients who are RARA positive.
Is Casey O'Connell, MD currently recruiting for clinical trials?
Yes, Casey O'Connell, MD is currently recruiting for 3 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Casey O'Connell, MD has studied deeply?
Yes, Casey O'Connell, MD has studied treatments such as Curcumin/ Demethoxycurcumin/Bisdemethoxycurcumin-containing Supplement, Atezolizumab, Guadecitabine.
What is the best way to schedule an appointment with Casey O'Connell, MD?
Apply for one of the trials that Casey O'Connell, MD is conducting.
What is the office address of Casey O'Connell, MD?
The office of Casey O'Connell, MD is located at: University of Southern California, Los Angeles, California 90033 United States. This is the address for their practice at the University of Southern California.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.